β-Nicotinamide Mononucleotide (NMN)
Kwanan nan, akwai labari mai daɗi a fannin NMN - bayan cikakken nazari da kwamitin ƙwararru na ƙungiyar da ke da iko a Hukumar Abinci da Magunguna ta Amurka (FDA) ta yi, an amince da kayayyakin NMN na Shangke Biopharmaceutical (Shanghai) Co., Ltd. (wanda daga baya ake kira "Shangke Bio") ta hanyar amincewar Hukumar FDA NDI ta Amurka, wanda ya tabbatar da cewa ana iya amfani da kayan NMN ɗinta a hukumance wajen samarwa, tallace-tallace da kuma tallata kayan abinci a Amurka, kuma ana iya samun su a gidan yanar gizon hukumar FDA a matsayin sabon kayan abinci na abinci, mai lamba 1247.
FDA NDI ita ce mafi mahimmancin tsarin bayar da takardar shaida a kasuwar Amurka. Samun wannan takardar shaidar ba wai kawai yana nufin cewa aminci da ingancin kayayyakin Shangke Bio suna da inganci ba.an san shi sosai, amma kuma yana da amfani ga ci gaba da daidaita masana'antar NMN a cikin dogon lokaci.
| Sunan Sinadarai | β-Nicotinamide Mononucleotide |
| Ma'ana iri ɗaya | NICOTINAMIDE-1-IUM-1-BETA-D-RIBOFURANOSIDE 5'-PHOSPHATE |
| Lambar CAS | 1094-61-7 |
| Nauyin kwayoyin halitta | 334.22 |
| Tsarin Kwayoyin Halitta | C11H15N2O8P |
| EINECS: | 214-136-5 |
| Wurin narkewa | 166°C(Disamba) |
| zafin ajiya. | -20°C |
| narkewa | DMSO (Dan kaɗan, Mai Zafi), Methanol (Dan kaɗan), Ruwa (Dan kaɗan) |
| siffa | Tauri |
| launi | Fari zuwa Rawaya |
| Merck | 13,6697 |
| BRN | 3570187 |
| Kwanciyar hankali: | Mai Tsabtace Ruwa sosai |
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
| Kayan Gwaji | Bayani dalla-dalla |
| Bayyanar | Foda mai launin fari zuwa fari |
| Abubuwan da ke cikin sodium | ≤1% |
| ƙimar pH (100mg/ml) | 2.0~4.0 |
| Tsarkaka | ≥99.0% |
| Yawan ruwa | ≤1% |
| Karfe masu nauyi | <10ppm |
| Arsenic | <0.5ppm |
| Jagora | <0.5ppm |
| Mercury | <0.1ppm |
| Cadmium | <0.5ppm |
| Sauran sinadaran da ke narkewa | Ethanol≤1000ppm |
| Jimlar Adadin Kwayoyin Halitta Masu Kama da Iska | <750cfu/g |
| Yis & Mould | <25cfu/g |
| Jimlar coliform | ≤0.92MPN/g |
| E. Coli | Mara kyau |
| Salmonella | Mara kyau |
| Staph. Aureus | Mara kyau |
| Gwaji (bisa tushen ruwa) | ≥99.0% |
| Matsakaicin ƙirjin ƙirji | ≥95% |
| Yawan yawa | Rahoton don ƙarin bayani |
Kunshin:Kwalba, jakar foil ta Aluminum, 25kg/Kwatin Drum, ko kuma bisa ga buƙatar abokin ciniki.
Yanayin Ajiya:A ajiye a cikin akwati mai matsewa, mai jure haske, don ajiya na dogon lokaci, a ajiye a zafin 2-8°C ko ƙasa da haka.
Nicotinamide Mononucleotide (NMN) wani sabon nau'in bitamin B3 ne wanda ke zama mataki 1 na gaba ga NAD+ (Nicotinamide Adenine Dinucleotide). NMN shine farkon maido da NAD+ na tantanin halitta da aka tabbatar yana da tasiri wajen dawo da tantanin halitta a cikin jiki.
Nicotinamide Adenine Dinucleotide (NAD) yana ɗaya daga cikin ƙwayoyin halitta mafi mahimmanci da ban sha'awa a jiki. Ana buƙatarsa don halayen enzymatic sama da 500 kuma yana taka muhimmiyar rawa wajen daidaita kusan dukkan manyan hanyoyin halittu (Ansari da Raghava, 2010). Fiye da komai, yana iya ba mu damar rayuwa mai koshin lafiya da tsayi.
Nicotinamide Adenine Dinucleotide (NAD) yana wanzuwa ko dai a cikin sifar oxidized (NAD+) ko kuma a cikin sifar ragewa (NADH), waɗanda sune mahimman abubuwan haɗin gwiwa na wasu oxidases.
Kamfanin SyncoZyems a matsayin kamfanin farko da ya sami amincewar FDA NDI NMN na samar da kayan masarufi, yana wakiltar jami'in FDA ya amince da NMN a matsayin sabon nau'in kayan da za a iya amincewa da su don sinadaran kari na abinci a Amurka.
